Target intelligence / Profile preview

MT-ND4L pseudogene 32 (MTND4LP32)

Target
MTND4LP32
Molecular classification
Other (Pseudogene, non-coding DNA)
01

Overview

MT-ND4L pseudogene 32 is a nuclear mitochondrial pseudogene—a segment of nuclear DNA derived from the mitochondrial genome that does not encode a functional protein[3]. The functional counterpart, MT-ND4L (mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L), encodes a structural subunit of mitochondrial respiratory complex I, which plays a central role in the electron transport chain and cellular energy generation[1][2][4]. However, pseudogenes like MTND4LP32 do not participate in these functions; they are remnants of evolutionary gene transfer events and are typically nonfunctional[3]. Key clarifications: - MT-ND4L pseudogene 32 is not a therapeutic target or receptor. - It is a non-coding pseudogene and has no established biological or pharmacological role. - If inquiry was for the functional gene/protein, "MT-ND4L," a mitochondrial electron transport chain subunit, see MT-ND4L (ND4L) for disease relevance, molecular classification (enzyme, oxidoreductase), and associated disorders such as Leber hereditary optic neuropathy[2][4]. If you require information on the functional MT-ND4L gene or protein, those details can be provided, but the pseudogene MTND4LP32 itself is non-functional and not a druggable or diagnostic target[3].

Other names
MT-ND4L pseudogene 32MTND4LP32mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L pseudogene 32
02

Biological functions

None (pseudogenes do not have established biological functions in coding proteins or serving as traditional molecular targets)
03

Disease associations

None specifically assigned; functional MT-ND4L gene (not the pseudogene) is implicated in mitochondrial diseases, but pseudogenes are non-coding

Beyond the preview

Go deeper on MT-ND4L pseudogene 32 (MTND4LP32).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MT-ND4L pseudogene 32 (MTND4LP32).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call